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Objective: To describe the preparation of nano emodin transfersome (NET) and investigate its effect on mRNA
expression of adipose triglyceride lipase (ATGL) and G0/G1 switch gene 2 (G0S2) in adipose tissue of diet-induced
obese rats.
Methods: NET was prepared by film-ultrasonic dispersion method. The effects of emodin components at different
ratios on encapsulation efficiency were investigated.The NET envelopment rate was determined by ultraviolet
spectrophotometry. The particle size and Zeta potential of NET were evaluated by Zetasizer analyzer. Sixty male SD
rats were assigned to groups randomly. After 8-week treatment, body weight, wet weight of visceral fat and the
percentage of body fat (PBF) were measured. Fasting blood glucose and serum lipid levels were determined. The
adipose tissue section was HE stained, and the cellular diameter and quantity of adipocytes were evaluated by light
microscopy. The mRNA expression of ATGL and G0S2 from the peri-renal fat tissue was assayed by RT-PCR.
Results: The appropriate formulation was deoxycholic acid sodium salt vs. phospholipids 1:8, cholesterol vs.
phospholipids 1:3, vitamin Evs. phospholipids 1:20, and emodin vs. phospholipid 1:6. Zeta potential was −15.11 mV,
and the particle size was 292.2 nm. The mean encapsulation efficiency was (69.35 ± 0.25)%. Compared with the
obese model group, body weight, wet weight of visceral fat, PBF and mRNA expression of G0S2 from peri-renal fat
tissue were decreased significantly after NET treatment (all P < 0.05), while high-density lipoprotein cholesterol
(HDL-C), the diameter of adipocytes and mRNA expression of ATGL from peri-renal fat tissue were increased
significantly (all P < 0.05).
Conclusion: The preparation method is simple and reasonable. NET with negative electricity was small and uniform
in particle size, with high encapsulation efficiency and stability. NET could reduce body weight and adipocyte size,
and this effect was associated with the up-regulation of ATGL, down-regulation of G0S2 expression in the adipose
tissue, and improved insulin sensitivity.
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Obesity is now recognized as one of the most important
public health problems facing the world today. Epi-
demiological surveys from many countries show that the
mean weight of the population is increasing and that the
prevalences of clinically-significant overweight and obes-
ity are rising rapidly in adults and, of particular concern,
in children and adolescents [1]. Up to one-third of the
adults in some westernized countries are obese and over
two-thirds in certain smaller populations such as Pacific
Islanders; very few countries remain unaffected by obes-
ity [2]. WHO has estimated that 200 million people
worldwide were obese in 1995, rising to 300 million in
2000. Revised estimates suggest that 400 million people
aged 15 years were obese in 2005, with almost 800 mil-
lion overweight. By 2015, WHO predicts that these
numbers will increase to 2.3 billion overweight and 700
million obese [3].
The molecular biological mechanism underlying the
pathogenesis of obesity is fat production more than fat
decomposition. When it comes to lipolysis, well-known
HSL is not the only lipase involved, as HSL-knockout
mice show normal basal lipolysis and some residual re-
sponse to catecholamines [4]. An important player is a
novel lipase, ATGL, which confers most of the residual
lipolytic activity in HSL-knockout mice [5]. In mouse
adipocytes, HSL and ATGL together account for 95% of
total triacylhydrolase activity [6]. At present, the respect-
ive roles of HSL and ATGL in human fat cell lipolysis
have not been well established. ATGL is activated by a
cofactor, comparative gene identification (CGI)-58. Be-
cause CGI-58 interacts with perilipins on the surface of
the lipid droplets, a complex inter-play has been pro-
posed between ATGL, perilipins and CGI-58 [7]. Both
PKA and PKG phosphorylate and activate human HSL.
Thus, the catecholamine and natriuretic peptide path-
ways converge on HSL to induce lipolysis inhuman fat
cells, while ATGL participates in basallipolysis. In mice,
ATGL seems to participate in stimulated lipolysis be-
cause ATGL deficiency causes a drastic reduction in
stimulated lipolysis and ATGL is required for PKA-
stimulated lipolysis [4].
G0S2 is a negative regulator of ATGL that mediates
fat decomposition through biding to ATGL. G0S2 is
highly expressed in adipose tissue and cell differenti-
ation. The results of analysis on GOS2 function in cell
cultures in vitro showed that G0S2 directly binds to
ATGL, thus inhibiting the activity of TAG hydrolase
and attenuating ATGL-mediated fat decomposition [8].
Over expression of G0S2 in lipid droplets of HELA
cells could prevent ATGL-mediated fat degradation. In
addition, G0S2 inhibits TAG hydrolysis of ATGL through
interacting with ATGL via its hydrophobic region and
patatin-like region of ATG. Endogenous G0S2 interferenceaccelerates basic and stimulatory fat decomposition. Over
expression of G0S2 decelerates adipose tissue and cell de-
composition, and therefore G0S2 plays a role in attenuat-
ing the action of ATGL, through which TAG hydrolysis is
regulated, or in other words, G0S2 inhibits the TAG
hydrolase activity of ATGL [9]. G0S2 also inhibits ATGL-
mediated transfer of lipid droplets. These findings provide
convincing evidence that G0S2 is an important ATGL-
mediated negative regulator of fat decomposition. What
we are interested in is whether G0S2 expression is regu-
lated by the newly developed external drugs and further
plays a coordinative role in reducing fat by affecting
ATGL. The purpose of our study was to confirm the above
hypothesis and ascertain whether it is possible to increase
fat decomposition by regulating G0S2 and ATGL [10].
There are two conventional modern medicines for the
treatment of obesity. One is Sibutramine, which reduces
fat by decreasing food intake and promoting heat pro-
duction; however, it may induce hypertension, tachycar-
dia and anorexia. The other is Orlistat, which is a lipase
inhibitor to decrease the absorption of diary fat in the
gastrointestinal tract [2]. But as it may induce stea-
torrhea and fat soluble vitamin deficiency, it has been
withdrawn from commercial availability. No other new
weight-reduction drug has been approved by the Food
and Drug Administration of China, except for a few lo-
cally certified trandermal patches and beauty creams.
Chinese herbal medicines have good therapeutic effects
on obesity. Emodin has been shown to have a weight-
reduction effect in obese tats. It can also lower lipid
levels and reduce the severity of fatty liver [11]. Studies
on pharmacochemistry of emodin showed that it is lipo-
philic [12]. TCM external therapy is also a means of re-
ducing weight. External medicinal friction and massage
also have the weight-reduction effect [13]. Inspired by
these findings, we postulated whether it was possible to
use emodin as an external rubbing and transdermal drug
to regulate ATGL and G0S2 and promote fat decompos-
ition so as to achieve systemic weight reduction, know-
ing that emodin is lipophilic and can pass through the
skin to the subcutaneous fat layer. Compared with oral
medications, transdermal drugs are much safer.
Emodin is one of the ingredients of Chinese traditional
herbs, and its molecular formula is C15H10O5, and is re-
ported to have notable effects on inflammation, hepatocyte
injury and liver fibrosis etc (see Figures 1 and 2). In China,
emodin has been used as a clinical medication to treat
other diseases such as viral hepatitis, cardiac arrhythmia
and skin inflammations. In addition, the mitigation of em-
odin has a protective effect on gastric mucosa and certain
protective effects against constipation [11]. Recent evi-
dence indicates that emodin can significantly inhibit the
weight gain of high-fatted rats, regulate blood lipids and
blood glucose metabolism disorders, enhance anti-lipid
Figure 1 The molecular formula picture of emodin.
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tioned above paragraph, it is postulated that emodin may
also play an important role in the treatment of obesity by
lipolysis and inhibiting proliferation of adipocytes.
Transfersomes are new dose forms developed rapidly
in recent years. They can effectively penetrate the skin
that is several times larger than themselves, with high
permeability and flexibility. The transfersome structure
is similar to the biological membrane and can serve as a
multi-functional directional drug vector. Sufficiently de-
formable transfersome can penetrate or cross the intact
skin barrier [14]. They were first developed as a carrier
preparation in the 1960s, and clinically used in the
1990s [15]. In this study, transfersomes as medicineFigure 2 The picture of the traditional chinese herb
emodin ingredient.carriers could expand the therapeutic index of the medi-
cine and reduce the possible adverse effect by improving
skin permeation and keeping drug in the skin, which is
the advantage of this study compared with others re-
ported liposomes [16]. Otherwise, the poor skin per-
meation of emodin was a challenge to the development
of emodin transdermal delivery system, which is the
problem of current preparation technology for emodin
nano-liposomes. The resulting drug delivery can be var-
ied systematically: depending on the precise application
conditions and carrier design, between 100% and ≤5% of
applied drug is deposited in the outermost skin region
[17,18]. Owing to the good skin penetration capability of
the transfersomes, we are in the position to low the ap-
plied doses and nevertheless achieve intra-cutaneous
drug concentration and distribution profile qualitatively
[19]. We have accumulated some experience in the re-
search and preparation of transfersomes and nano-
liposomes [20].
Therefore, in the present study, we attempted to use
emodin to prepare a nano transfersome emulsion and
make a pharmacological study on it in accordance with
the requirements on new nano transfersome emulsions.
At the same time, we intended to use the nano emodin
transfersome (NET) emulsion for external rubbing mas-
sage of the abdomen in a rat obesity model induced by
high-fat chows to observe its weight-reduction effect
and its effect on the mRNA and protein expressions of




Lecithin was procured from Lipoid Corporation. (Germany,
Batch number: 790618-1/902), Deoxycholic acid sodium
salt and Cholesterol were from Guangfu Fine Chemical
Co., Ltd. (Tianjin, China). emodin was obtained from Xi’an
Haijia Biotechnology Co., Ltd (Batch number: 519-02-8).
emodin (reference substance) was purchased from National
institute for the control of pharmaceutical and biological
products. Sephadex G-50 was purchased from Beijing
Haidian Huiyou fine chemical plant. Phosphate butter
(PBS) was prepared in our laboratory. All other chemicals
were of analytical reagent grade and were used without any
further purification.
Instruments
NET was prepared in Rotary evaporator on the model
N1001 and Digital water bath on the mode SB1000 of
Shanghai Eyela Corporation. Transmission electron micro-
scope (TEM) was performed on the model H7500 of
Hitachi Co., Ltd. Zetasizer analyzer on the model Delsa
Nano was purchased from Beckman coulter. lnc (USA).
Organic syringe filters (13 mm× 0.22 um) were purchased
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cleaner on the model SB100DT was obtained from Ningbo
scientz biotechnology Co., Ltd. YL9100 HPLC chroma-
tograph was provided by Hefei Guochang Analytical In-
struments Co., Ltd. Hypersil ODS-2 column (250 mm×
4.6 mm, 5 um) was prepared by Shanghai Troody technol-
ogy Co., Ltd. The variable-wavelength UV detector (Model
756PC) was purchased from Shanghai Spectrum Co., Ltd.
Methods and results
Preparation method of nano emodin transfersomes (NET)
To prepare the NET with reverse-phase evaporation
method, we dissolved sufficient quantum of lecithin,
cholesterol in ether, and emodin in 5 ml PBS (aqueous
solvent: organic solvent = 1:3 ~ 1:6). The solution was
transferred into a pear shape flask, and introduction
10 min after ultrasonic cleaning to form W/O emulsion
cream. The flask was then attached to a rotary evapor-
ator to evaporate the organic solvent under a vacuum at
28°C. Dry the solution until colloidal state film is formed
on the inner wall of the flask. Take off the flask, add
6.25 mg deoxycholic acid sodium salt and l0 ml PBS
(pH 7.2) into the flask. Connect the flask to the rotary
evaporator again, rotate under the 35°C and atmospheric
pressure with the speed of 40 r/rain, and make it into
suspension. The transfersomes suspension was obtained
after sonicated for 15 min in ultrasonic cleaner and filter
through microporous membrane about 0.22 um.
The standard curve of emodin
Dissolve 10 mg emodin reference substance in 10 mL
distilled water as the standard solution (1 mg/mL), then
precisely scale 0.6, 0.8, 1.0, 1.2, 1.4 mL to volumetric
flasks and added into mobile phase to 10 mL. Respect-
ively inject 20 uL into ODS-2 column from 0.06, 0.08,
0.10, 0.12, 0.14 mg/mL obtained solution. Take absorb-
ance A as X-axis and drug concentration C (mg/mL) as
Y-axis in Figure 3 to determine the regression equation
that is:A = 38.444C - 0.0496 (r =0.9963). The resultFigure 3 The standard curve of emodin by UV method.indicates that emodin has a good linear relationship be-
tween the scale of 0.005 ~ 0.04 mg/mL.
Determination of the entrapment efficiency of NET
The encapsulation efficiency was measured by RP-HPLC.
HPLC conditions were as follows: a Hypersil ODS column
(250 mm× 4.6 mm, 5 um), room column temperature, the
mobile phase consisting of 0.1% H3PO4 solution: aceto-
nitrile (95:5) (the pH 3.13 adjusted with triethylamine)
[21]. The injection volume was 20 uL, the flow rate was
1.0 mL/min, and the UV wavelength was set at 215 nm.
The free emodin was separated by Sephadex G-75 column
from NET. An aliquot of 0.5 mL transfersomes suspension
was added into molecular sieve chromatography on a
Sephadex G-75 column (300 mm× 26 mm) which was
previously equilibrated with PBS (pH 7.0) [22]. PBS
(pH 7.0) was used as eluent and the flow rate was 1.0 mL/
min. The emodin peak and transfersomes peak were col-
lected and RP-HPLC was used to determine peak areas.
The entrapment efficiency was calculated according to
the following equation:
E% ¼ 1－ Mfree=NETotalð Þ  100%
Where NETotal was the total amount of drug in trans-
fersomes suspension, and Mfree was the amount of drug
which is not encapsulated in transfersomes [23]. Choose
the best formulation and measure the average entrap-
ment efficiency of NET, the result was (69.35 ± 0.25)%.
Select the optimum formula of NET
Orthogonal design was used to optimize the preparation
methods on the basis of single factor selection. List 4 in-
vestigative factors which played important role in the
encapsulation efficiency of NET: the weight ratio of
cholesterol and phospholipids (A), the emodin dosage
(B), the pH value of PBS (C) and the ether volume (D),
and respectively design 3 levels in each factor [24] (see
Table 1).
Table 1 Factors and levels of the orthogonal test
Levels A B C D
Cholesterol/phospholipids (mg/mg) Emodin dosage (mg) pH value of PBS Ether volume (ml)
1 1:1 10 6.8 15
2 1:2 20 7.0 20
3 1:4 30 7.2 25
Lu et al. Journal of Translational Medicine 2014, 12:72 Page 5 of 14
http://www.translational-medicine.com/content/12/1/72Results of L9 (3
4) orthogonal experiment
The L9 (3
4) orthogonal Table 2 was designed to arrange
experiment procedures. The content of emodin was used
as quality control standards and the encapsulation effi-
ciency as evaluation index. Table 2 illustrated that the
degree of impact on the entrapment efficiency were as
follows: factor C > A > D > B. Statistical analysis showed
that A has a significant difference, C, D have difference,
B has little effect. So we choose C3A2D2B2, and the ap-
propriate formulation was as follows: the weight ratio of
cholesterol and phospholipids was 1:2, the amount of
emodin was 10 mg, the pH value of PBS was 7.2 and the
ether volume was 25 mL.Shapes and sizes of the NET
Dilute stock sample with PBS, then use negative staining
sample by 2% phosphotungstic acid (PTA), and observe
the shape of transfersomes under TEM (see Figure 4).
Suspension of NET was round and uniform and ap-
peared milky.
The average size of NET determined by Zetasizer and
particle analyzer was 292.2 nm, and the polydispersity
index was 0.009. The result of size distribution was
shown in Figure 5. The Zeta potential was −15.11 mV,
as shown in Figures 6 and 7.Table 2 Results of L9 (3
4) orthogonal experiment of prescript
Levels A B













R 11.13 2.32Stability experiment of the NET
Store NET samples at room temperature (25°C) and re-
frigerator (4°C) in three months, respectively, then we ob-
served the shape and dispersity of transfersomes, measured
the entrapment efficiency of NET samples. In cold storage
conditions, we found that transfersomes samples, which
placed in one month, were not changed in appearance,
placed in two months occured statified phenomenon, but
gently shaked samples could back to the colloid state as
usual. And at room temperature storage in a month, trans-
fersomes appeared irreversible precipitation phenomenon,
the particle size turned bigger. These results illustrated
that, under room temperature conditions, transfersomes
were instability, appeared precipitation, and in cold storage
conditions, the particle size had increased, but still accord
with the requirement. Indicating that transfersomes need
to be placed in cold storage conditions [25]. The different
results of entrapment efficiency and particle size were




Reagents and drugs Oligo(dT) primers, dNTP and
MMLV reverse transcriptase were purchased from
Dongyang Bio-Technology Co. (Shanghai, China), Trizolion
C D Encapsulation














Figure 4 TEM photograph of nano emodin transfersomes.
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RNase inhibitor from Lingfei Company (Wuhan, China).
Taq polymerase and DNA marker were obtained from
Tiangen Biochemical Technology Co. (Beijing, China).
Primers were synthesized by Yingjun Biotechnology Co.
(Shanghai, China).Animals and chow All animal studies were carried out
in compliance with the Principles for Care and Use of
Laboratory Animals approved by the Laboratory of Tongji
Medical College, China. 60 clean grade just weaning SDFigure 5 Size distribution of nano emodin transfersomes.male rats, with weight of 50 ± 5 g, were purchased from
the Experimental Animal Center of Wuhan University,
China. The formula of standard rat chow contained the
standard powder 35 g, wheat bran 15.5 g, soybean meal
20 g, corn flour 20 g, soybean oil 0.5 g, fish meal 5 g, bone
meal 2.5 g, yeast extract 1 g, and salt 0.5 g in each 100 g,
with total energy 14.03 KJ/g ( protein 20.90%, fat 10.38%,
and carbohydrate 68.72%). The formula of high-fat diet
was given as follows: each 100 g contains standard rat diet
60 g, lard 15 g, dried egg yolk powder 10 g, skim milk 8 g,
casein 5 g, sugar 2 g, total energy 19.22 KJ/g (protein
19.45%, fat 49.85%, carbohydrate 30.70%) (20). The feed
was mixed by adjustable high-speed electric homogenizer
(FSH-2, Jiamei Instrument Co., Jiangsu, China) and stored
at room temperature. A week worth of the feed was pre-
pared at a time.Experimental methods
The topical emulsion of nano emodin transfersome
The nano emodin transfersome (NET) prepared as des-
cribed in Part One of the present study was added to gly-
cerol and sodium carboxymethyl cellulose at a weight ratio
of 30:3:1, ground and mixed well, and finally prepared into
a nano emodin transfersome emulsion for topical use.Preparation of emodin oral solution Emodin oral solu-
tion was composed of Chinese herbal medicine emodin
(Hubei) in a 1.5:1 (w/w) ratio. All the herbal drugs were
purchased from Ginkgo Traditional Chinese Herbal
Company (Wuhan, China). All the herbal drugs were
soaked in 8 volumes of distilled water (1:8, w/v) for 12 h
Figure 6 Zeta potential and mobility distribution of NET.
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times. The mixture was filtrated and concentrated to a
concentration equivalent to 2.7 g raw herbs in 1 mL ex-
tract. The extract was stored at 4°C until use.
Grouping and induction of obesity All rats were ran-
domly assigned to one of two groups, the model group
(n = 50) or the normal control group (n = 10). AfterFigure 7 Measurement results of EOS Plot.adaptation with free access to regular rat chow and tap
water for one week, 40 rats in the model group were fed
with high-fat diet, 25 g for each rat per day, and 10 rats in
the normal group were fed with standard rat chow. All
rats were maintained in the animal facility individually and
housed in a controlled room, with a temperature of 20 ±
5°C, humidity of 55 ± 5%, and 12 h-dark and 12 h-light
cycle. The criterion for judging successful induction of
Table 3 Entrapment efficiency (EE) and particle size of




Size (nm) EE (%) Size (nm) EE (%)
0 297.4 68.83 297.4 68.83
1 463.3 53.46 348.6 67.80
2 675.4 41.09 376.8 66.04
3 713.9 34.78 383.7 65.31
4 - 21.17 390.1 62.68
Lu et al. Journal of Translational Medicine 2014, 12:72 Page 8 of 14
http://www.translational-medicine.com/content/12/1/72obesity was 20% or more increase in body weight as com-
pared with the average weight of the control group. 39 rats
in the model group that met the criterion were randomly
divided into 4 groups: the model group (n = 9), topical
NET group (n = 10), the oral emodin solution group (n =
10) and the massage group (n = 10).
Treatment and drug delivery methods At first, the ab-
dominal hairs of all animals were faded away using 8% so-
dium sulfide, and then intervened by application of the
drug. Animals in the blank control group were massaged
with the same amount of distilled water on the abdomen
around the acupoint “Shenjue” and “Zhongwan” in a
clockwise direction and a circling way at a rate of 60 cir-
cles per minute, knowing that these two acupoints have
the effect of regulating the endocrine function as recorded
in traditional Chinese medicine. Each episode lasted 2 mi-
nutes × 3 at a 1-minute interval. The rats in the emodin
oral solution group received emodin solution at 2.7 g/kg/
day, those in the NET group received topical emulsion of
NET at 4 g/kg/day, and those in the model group and the
normal group, emodin oral solution group received topical
distilled water of the same volume. The exterior daub
number is the same as the topical NET group. The treat-
ment administration was performed at 8:30 a.m. every day
for 8 weeks. The fur, feces, food intake, vitality and activ-
ities of rats were observed daily, and the rats were weighed
once at 8:00 a.m. every other day by using an electronicFigure 8 Body weight changes after high-fat diet. Note: △P < 0.01, as canalytical balance with 0.1 g accuracy (M248886, Zhongxi
Chemical Glass Instrument Co., Beijing, China).
Measurement program of parameters
Measurement of body weight and obesity parameters
At the end of the treatment, rats were weighed and sacri-
ficed, and 2 mL fasting blood (fasting for 12 h) was taken.
The serum samples were collected by centrifuging the
blood samples at 3 000 rpm for 10 min (Certrifuge-5415R,
Eppendorf Co., Germany). The liver and retroperitoneal,
epididymal adipose tissues were removed and weighed
(wet weight of visceral fat) after excess blood and tissue
fluid were dried by filter paper. PBF was calculated
(PBF = wet weight of visceral fat/body weight × 100%).
Measurement of blood biochemical parameters
Serum triglycerides (TG), total cholesterol (TC), high-density
lipoprotein cholesterol (HDL-C) and low-density lipoprotein
cholesterol (LDL-C) were measured using an automatic
biochemical analyzer (AU-400, Olympus Co., Japan). The
serum insulin was determined by the method of radioimmu-
noassay. The radioactive count of sediments was determined
by using a radioimmunoassay calculator (GC-911, Science
and Technology Industrial Corporation of CUST, China).
Light microscopy of adipose and liver tissue
A small block of adipose tissue was dissected from the
left epididymis and merged in 4% paraformaldehyde for
24 h. The fixed adipose tissue was embedded in paraffin
and sliced for HE staining. The quantitative analysis on
the size of adipocytes was conducted by an automatic
medical color image analysis system (HM IAS-2000,
Champion Co., China). The light microscopy protocol of
liver tissue are the same steps.
Statistical analysis
Statistical analysis of data was performed with the one-
factor analysis of variance (SPSS so ware, version 13.0,
SPSS Inc). The results were expressed as mean SDompared with the control group.
Table 4 Comparison of general obesity parameters among groups (x ± S)





Before treatment After treatment
Control 10 222.89 ± 5.28 327.33 ± 18.18 13.46 ± 5.58 6.89 ± 1.86 2.37 ± 0.44
Model 9 295.34 ± 16.61△ 442.44 ± 31.23△ 12.84 ± 1.71 9.67 ± 1.76△ 2.42 ± 0.40
Massage 10 309.04 ± 30.18△ 423.13 ± 58.99△ 12.05 ± 1.56 9.94 ± 2.40△ 2.44 ± 0.49
Oral 10 314.83 ± 15.25△ 378.28 ± 28.79△▲☆ 13.45 ± 1.39 8.16 ± 1.87△▲☆ 2.35 ± 0.37
NET 10 305.06 ± 24.10△ 383.175 ± 33.65△▲☆ 12.82 ± 1.59 9.91 ± 2.79△★ 2.38 ± 0.99
Notes: △P < 0.05, compared with the control group; ▲P < 0.05, compared with the model group; ☆P < 0.05, compared with the Massage group; ★P < 0.05,
compared with the Oral group.
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Results
The body weight changes of rats after high-Fat diet
The body weight was similar between the normal con-
trol group and the obese model group before initiation
of the high-fat diet (P > 0.05). At the end of 6 weeks on
the high-fat diet, the body weight of obese rats in model
group was significantly increased compared with that of
the normal group (P < 0.01, see Figure 8). Besides, there
is no change in food intake and physical movement
which have been measured upon different treatments.
Comparison of general obesity parameters
Compared with the normal group, there was significant dif-
ference in body weight between the groups before interven-
tion (P < 0.05. The body weight of the model group was
still higher than that of the normal group by the end of
treatment (P < 0.05). Compared with the model group, the
body weight of the massage, oral and NET groups reduced
significantly (P < 0.05). Compared with the massage group,
the body weight of the oral and NET group reduced signifi-
cantly (P < 0.05), and there was no significant difference in
weight reduction between the oral and NET groups (P >
0.05). There was no significant difference in liver wet
weight between the groups (P > 0.05). The liver wet weight
of all intervention groups was higher than that of the nor-
mal group (P < 0.05), and the liver wet weight of the oral
group was lower than that of the massage and NET groups
(P < 0.05). There was no significant difference in the body
fat ratio between the groups (P > 0.05) (see Table 4).Table 5 Comparison of TG, TC, HDL-C and LDL-C among grou
Group n TG (mmol/L) TC (m
Control 10 1.01 ± 0.19 2.15 ±
Model 9 1.31 ± 0.22△ 2.18 ±
Massage 10 1.23 ± 0.12△ 1.98 ±
Oral 10 0.86 ± 0.27▲☆ 2.04 ±
NET 10 0.99 ± 0.27▲☆ 2.01 ±
Notes: △P < 0.05, compared with the control group; ▲P < 0.05, compared with the mComparison of serum lipids parameters
There was no significant difference in serum TC and
LDL between the groups (P > 0.05). Compared with the
model and massage group, the body weight of the oral
and NET group reduced significantly after treatment
(P < 0.05), and there was no significant difference be-
tween the NET and oral groups (P > 0.05). There was no
significant difference in TG between the model and mas-
sage groups (P > 0.05). HDL level of the NET and oral
groups was higher than that of the normal, model and
massage groups (P < 0.05), and there was no significant
difference between NET and oral groups (P > 0.05)
(Table 5).
Comparison of general features of the epididymal
adipocytes
The equivalent diameter, perimeter and area of adipo-
cytes in the model group significantly increased com-
pared with the normal control group (P < 0.01), and the
number of adipocytes decreased as quantified in a single
field under × 400 original magnification (data not shown,
see Figure 9). All values of the Oral group and NET
group resulted in significant reduction in comparison to
that of untreated obese rats in the obese model group
(P < 0.01, P < 0.05, respectively), with greater a reduction
for all parameters for the oral group (see Table 6).
Histomorphological observation on the liver
The liver tissue was HE stained and observed under an
optical microscope (× 200 and × 400). It was found that
the structure of the hepatic lobules was intact in the
normal group, with radiating arrangement of hepatic cellps (x ± S)
mol/L) HDL-C (mmol/L) LDL-C (mmol/L)
0.23 1.58 ± 0.24 0.52 ± 0.21
0.43 1.41 ± 0.32 0.49 ± 0.29
0.31 1.43 ± 0.28 0.57 ± 0.28
0.40 2.76 ± 0.38△▲☆ 0.47 ± 0.20
0.20 2.67 ± 0.31△▲☆ 0.53 ± 0.21
odel group; ☆P < 0.05, compared with the Massage group.
Figure 9 Histological changes of epididymal adipose tissue in rats (HE Stain, × 400).
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http://www.translational-medicine.com/content/12/1/72cords around the central vein, and clear and uniform
Disse’s spaces; hepatocytes were relatively large in size
and polygonic in shape, with rich cytoplasm and large
nuclei in the center without steatosis seen. In the model
and massage groups, the structure of hepatocytes and
Disse’s spaces were not clear enough; large numbers and
different sizes of circular vacuoles were seen in the cyto-
plasm, presenting as macrovesicular steatosis. In the oral
group, the hepatocytes were structurally intact and ar-
ranged in a radiating way, with clear and uniform Disse’s
spaces and nuclei; a small amount of macrovesicular
steatosis was vaguely seen in the cytoplasm. In NET
group, hepatocytes were structurally intact, with clear
and uniform Disse’s spaces and nuclei, presenting as sev-
eral steatotic vacuoles (see Figure 10).
Comparison of ATGL and G0S2 protein expression in
adipose tissue
Compared with the normal group, the expression level
of ATGL protein was slightly lower and the expression
level of G0S2 protein was higher in the adipose tissue of
the model group (both P < 0.05). The expression level of
ATGL protein in the massage, oral and NET groups was
high than that in the model group (P < 0.05). The ex-
pression level of ATGL protein in the oral and NET
group was higher than that in the massage group (P <
0.05). The expression level of G0S2 protein in the massage
and NET groups was lower than that in the model group
(P < 0.05), and the expression level of G0S2 protein in the
oral and NET groups was lower than that in the massage
group (P < 0.05) (see Table 7 and Figures 11, 12).
Conclusions
The treatment of obesity is confronted with a stern chal-
lenge at present. With the commercial withdrawal ofTable 6 Comparison of equivalent diameter, perimeter and a
Group n Equivalent diameter (um)
Control 10 54.81 ± 9.78
Model 9 79.87 ± 14.67△
Massage 10 75.61 ± 12.43△
Oral 10 52.87 ± 18.45▲☆
NET 10 59.98 ± 16.65▲☆
Notes: △P < 0.01 compared with the control group; ▲P < 0.05 compared with the mSibutramine and Orlistat, no effective and low-toxicity
new weight-reduction drug has been developed and mar-
keted. Our and other studies have demonstrated that
Matrine could reduce the body weight and Lee’s indexes
of obese rats, as well as fasting insulin, TG and cho-
lesterol levels [17]. By taking advantage of the TCM the-
ories, our study not only holistically confirmed that
Matrine could reduce the body weight and abdominal
fat weight of obese rats, decrease the size of fat cells and
increase the HDL-C level but gained insights into the
mechanism of Matrine in affecting the adipose tissue of
obese rats. Based on our previous work, the present
study, for the first time, used the thin-film dispersion
method to successfully prepare a nano NET emulsion.
The obtained TF carry negative charges and are small in
size and well distributed, with good entrapment effi-
ciency and stability. The result of external application
showed that it was able to relieve the pathological change
of fatty liver, reduce the peripheral fat content, increase
serum HDL-C, and reduce TG level. In addition, it could
also down-regulate the G0S2 protein expression in the
adipose tissue of obese rats and up-regulate the ATGL
protein expression. These mutually antagonistic effects
work together to reduce the body weight of obese rats.
There is no similar report available in the literature. The
mechanism of NET in the prevention and treatment of
obesity needs to be further studied, knowing that regula-
tion of G0S2 and ATGL may prove to be a new strategy
for the treatment of obesity.
The development of obesity is attributed to multiple
factors responsible for disordered homeostasis of fat me-
tabolism, increased fat synthesis and decreased fat de-
composition in the body. Studies have demonstrated
that multiple factors participate in and regulate fat me-
tabolism. ATGL and G0S2 are believed to play anrea of adipocytes among proups (x ± S)
Perimeter (um) Area (um2)
180.42 ± 27.75 2304.43 ± 763.34
297.32 ± 54.60△ 5134.45 ± 1689.43△
283.06 ± 40.60△ 4912.98 ± 1588.21△
171.32 ± 35.78▲☆ 2237.12 ± 687.02▲☆
225.21 ± 65.87▲☆ 2982.98 ± 1931.98▲☆
odel group; ☆P < 0.05, compared with the Massage group.
Figure 10 Histomorphological observation on the liver tissues (HE Stain, × 200 and × 400).
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Table 7 Comparison of ATGL and G0S2 protein
expression in the adipose tissue
Group n ATGL G0S2
Control 10 0.590 ± 0.011 0.716 ± 0.022
Model 9 0.437 ± 0.020△ 0.918 ± 0.028△
Massage 10 0.552 ± 0.023▲ 0.732 ± 0.025▲
Oral 10 0.702 ± 0.016△▲☆ 0.667 ± 0.018△▲
NET 10 0.705 ± 0.031△▲☆ 0.671 ± 0.035△▲
Notes: △P < 0.05 compared with the control group; ▲P < 0.05 compared with
the model group; ☆P < 0.05, compared with the Massage group.
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key enzyme in fat metabolism, and is expressed mainly
in murine white and brown fat tissues, and secondarily
in the cardiac muscle, skeletal muscle and testis [5,9].
ATGL mainly hydrolyzes triglyceride into diglyceride,
and therefore ATGL and HSL are believed to be a com-
mon rate-limiting enzyme for the reaction of fat decom-
position. The adipose tissue was increased remarkably in
ATGL knockout mice, presenting as TG accumulation
in multiple tissues, indicating that ATGL is a rate-
limiting enzyme of TG hydrolysis, playing an important
role in fat mobilization in fat tissues [26-28]. Other stud-
ies also reported that G0S2 is a negative regulator of
ATGL [28]. Zandbergen et al. reported that the level of
G0S2 mRNA expression was the highest in fat tissues,
and was up-regulated in the process of preadipocyte
differentiation into fat cells [29]. In vitro and cell-based
studies on G0S2 function showed that G0S2 directly
binds to ATGL, thus decreasing the ability of ATGL-
mediated fat decomposition by inhibiting the activity of
TAG hydrolase [30].
In the present study, we established a rat model of
alimentary obesity induced by feeding the animals withFigure 11 ATGL and G0S2 protein expression in the adipose tissue bywell-prepared high-fat chows for two weeks. After 6-week
feeding, the body weight of the animals in the model
group was 20% heavier than that in the normal group. In
addition, both wet weight ratio and body lipid ratio of the
internal organs of the animals in the model group were in-
creased. HE staining also showed that fat cells became sig-
nificantly larger as shown by optical microscopy. All these
indicate the successful establishment of the obesity model.
Animal studies have demonstrated that the expression of
ATGL mRNA was down-regulated markedly in db/db and
ob/ob obesity animal models, suggesting that the develop-
ment of obesity may be associated with the decreased level
of ATGL [6,25]. The result of the present study showed
that the expression level of ATGL protein in the model
group was slightly lower than that in the normal group,
which may be the reason for the increased fat synthesis
and excessive accumulation of fat in the body, resulting in
obesity. Our finding is grossly consistent with the results
of other studies.
The present study holistically confirmed that NET could
reduce body weight and abdominal fat weight of obese rats.
The biochemical parameters also showed that TG was de-
creased and HDL-C was increased after topical treatment
with NET. Compared with the model group, the equivalent
diameter, circumference and area of fat cells in the inter-
vention group were also decreased significantly. Patho-
logical observation showed that the liver tissue was
normal, suggesting that NET emulsion may affect the
process of energy consumption in fat metabolism. In sum-
mary, ATGL and G0S2 play an important role in energy
metabolism of the body. In the present study, we used the
WB technique to further observe its impact on ATGL and
G0S2 protein expression in the adipose tissue of obese rats.
The result showed that NET was able to down-regulate
G0S2 protein expression in the adipose tissue of obese rats,Western-blot.
Figure 12 Comparison of ATGL and G0S2 protein expression in the adipose tissue. Notes: △P < 0.05 compared with the control group;
▲P < 0.05 compared with the model group; ☆P < 0.05, compared with the Massage group.
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weight-reduction effect. The above pharmodynamic study
demonstrated that GOS2 and ATGL could regulate fat me-
tabolism, which is consistent the previous studies [31-33].
We also testified the effect of G0S2 in attenuating the ac-
tion of ATGL in rats in vivo. The blood biochemical pa-
rameters, pathological observation of the fat and liver
tissue, and molecular biological parameters obtained in our
study indicate that NET emulsion had a good weight-
reduction therapeutic effect equivalent to that of oral emo-
din, which is also consistent with our previous study [34].
But the therapeutic effect of the external NET emulsion is
better than that of massage in reducing body weight.
Emodin is a kind of water soluble molecules and hard to
be entrapped. Transdermal drug delivery system has been
accepted as potential non-invasive route of drug adminis-
tration, with advantages of avoidance of the first-pass me-
tabolism, sustained therapeutic action and better patient
compliance, though, its prevalent use is restricted due to
excellent impervious nature of skin. It is the greatest chal-
lenge for researchers to surmount the inherent limitations
imposed by stratum corneum of skin, for enhanced trans-
dermal drug delivery to achieve systemic therapeutic
concentration [35]. Transfersomes have shown immense
potential in drug delivery across the skin [36]. Since the
transfersomes has high hydrophilicity and flexibility. In
the role of hydration transfersomes could across l/10 ~ l/4
of itself diameter of the channel, made loaded drugs
through the skin barrier and even enter into the blood cir-
culation. Thus, preparing NET is a good way to improve
its entrapment efficiency.
The preparation method by reverse-phase evaporation
was simple and had high encapsulation efficiency, easy for
scale up preparation and research [37]. We choosed the
deoxycholic acid salt as surfactant, when the weight ratio
of deoxycholic acid salt and phospholipids was 1:8, theNET had well stability and high entrapment efficiency. The
experiment indicated that encapsulation efficiency was the
highest when the weight ratio of cholesterol and phospho-
lipids was 1:2, the amount of emodin was 10 mg, the pH
value of PBS was 7.2 and the ether volume was 25 mL. RP-
HPLC is the most widely used separation technique for
this application owing to its simplicity and general applic-
ability to emodin type alkaloids [38], which could deter-
mine entrapment efficiency accurately as well as emodin
quantity. The average entrapment efficiency of NET was
61.46 ± 0.25% by RP-HPLC determination. Zeta potential
is one of the important indexes of the surface charge of
ion, and also affected the stability of transfersomes sus-
pension liquid [39,40] transfersomes with negative po-
tential can reduce mutual gather and fusion, increase
the stability. The Zeta potential of NET prepared in this
experiment was −7.94 mV. And the particle size of
NET with negative charge was small and uniform, and
had some stability. The above methods for preparation
of NET and determination of its physicochemical proper-
ties, provide excellent separation and good precision, and
are relatively straight forward and reliable for both chro-
matographic conditions and sample preparation. Further-
more, the study of NET was not comprehensive, and need
further investigation.
The results of the present study may also provide
some inspirations and references for further research on
the preparation of nano materials and treatment of obes-
ity, and for the development of new weight-reduction
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